Advertisement
open access
Medical Conferences

Medical Conferences

  • Conference Reports
    • 2023 Medicom Conference Planning
  • Disease Areas
  • Other Medical News
  • Podcast
  • Videos
  • Education
  • About
    • Vacancies

Tag: ECZTRA

AD patients with stable response fare well with a monthly dose of tralokinumab

Presented By
Prof. Stephan Weidinger, University of Kiel, Germany
Trial
ECZTRA1 and 2
Conference
EADV 2021

18 November, 2021 13:25

Efficacious 2-year AD control with IL-13 inhibitor tralokinumab

Presented By
Prof. Andrew Blauvelt, Oregon Medical Research Center, USA
Trial
ECZTEND
Conference
EADV 2021

18 November, 2021 13:22

Meaningful sleep improvement with IL-13 inhibition

Presented By
Prof. Jonathan Silverberg, George Washington University, USA
Trial
Phase 3, ECZTRA
Conference
EADV 2020

17 December, 2020 14:33

Effects IL-13 blocker improves with longer treatment duration

Presented By
Prof. Eric Simpson, Oregon Health & Science University, USA
Trial
Phase 3, ECZTRA
Conference
EADV 2020

17 December, 2020 12:37

IL-13 blocker tralokinumab effective in AD

Presented By
Prof. Eric Simpson
Trial
ECZTRA
Conference
AAD 2020

6 August, 2020 07:06
site created by:   

© 2023 Medicom Medical Publishers.  All rights reserved. Terms and Conditions | Privacy Policy